HOME >> BIOLOGY >> NEWS
Studies show success of Mectizan partnerships

The development of the drug Mectizan (ivermectin) and its distribution worldwide have radically altered the consequences of onchocerciasis, or river blindness, which once blinded millions in Africa, and Latin America. Researchers at the Johns Hopkins Bloomberg School of Public Health conducted four new studies evaluating the Mectizan Donation Program, which was established by Merck and Co. Inc., the makers of Mectizan. They concluded that the now 17-year old Mectizan Donation Program is a successful and cost effective program for preventing the debilitating effects of river blindness. The researchers also believe that the public-private partnership forged by Merck through the Mectizan Donation Program should serve as a model for other companies and aid organizations seeking to prevent and treat other illnesses worldwide, such as AIDS and malaria. The studies are published in the current issue the journal Tropical Medicine and International Health.

On May 14, 2004, the School of Public Health and Merck and Co. Inc., will mark the successful work of the Mectizan Distribution Program with a symposium, "Controlling River Blindness: Achievements of a Public-Private Partnership." The event will be held from 12:15-1:30 p.m. at the School of Public Health in Baltimore, Md. and will feature discussions of the latest study findings from researchers from the School of Public Health and representatives from Merck and the Mectizan Donation Program.

"The Mectizan Donation Program is really one of the great public health success stories. It is the benchmark for all other disease prevention efforts in the developing world," said Gilbert Burnham, MD, one of the study authors and an associate professor in the School's Department of International Health.

Ivermectin, the compound from which Mectizan is derived, was originally found to be effective against parasites in farm animals. Realizing its potential as a human medicine, Merck and WHO conducted seven years of
'"/>

Contact: Tim Parsons
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
10-May-2004


Page: 1 2

Related biology news :

1. Monkey business: Studies show tiny callimicos have unusual characteristics
2. Studies offer new insight into HIV vaccine development
3. Studies suggest brain injury results from developmental exposure to alcohol, anesthesia, and lead
4. Studies show preventive value of food supplements
5. Studies probe rapid evolution of Chinese tallow trees
6. Studies of rare blood syndrome yield novel route to cancer
7. Studies dispute ultraviolet effect on amphibian population declines
8. Studies of spiders silk reveal unusual strength
9. Studies of genes in mice and common worm may accelerate research on blood diseases, cancers
10. Studies offer data on potential impact of Reminyl on caregiver burden in Alzheimers disease
11. Studies: Floyd, other major hurricanes of 99 caused significant changes in nations largest lagoonal estuary

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/9/2018)... ... August 08, 2018 , ... Specialty Med ... helps physicians bring the latest regenerative therapies and treatment options to their patients, ... 2018 in White Plains, NY. , The 2-day clinical collaboration ...
(Date:8/7/2018)... ... 2018 , ... Nurse practitioners and physician ... healthcare careers in the past year, according to the second annual survey of ... with a wide variety of career- and employment-related resources including physician/candidate database, job ...
(Date:8/7/2018)... ... 07, 2018 , ... Nanomedical Diagnostics , leading manufacturer ... titled, “Synthetic Molecules for Disruption of the Myc Protein-Protein Interface ” in ... Agile R100, described as a “ field-effect transistor (Bio-FET) platform ,” to produce ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... ... August 09, 2018 , ... Simpson Gumpertz ... (AEC) experts with building owners and managers for a full-day discussion on health ... symposium comes to Boston for the first time on Thursday, 13 September 2018, ...
(Date:8/1/2018)... ... August 01, 2018 , ... Roland ... of a proprietary biofield energy treated supplement that potentially improves the anti-inflammatory ... systemic and organ-specific inflammation, as well as, immune function response. The following ...
(Date:7/31/2018)... ... 31, 2018 , ... Mahoney Environmental , a leading ... new website. The new website has been designed with improved functionality and navigation, ... Innovative to build a website created for the customer. The newly redesigned site ...
(Date:7/25/2018)... ... July 25, 2018 , ... Eileen Meagher, ... of a biofield energy treated nutraceutical to improve skin health parameters including anti-wrinkling, ... skin health and reported the following results:,     More than ...
Breaking Biology Technology:
Cached News: